chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concurrent medical conditions included Type 2 diabetes mellitus.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced FATIGUE (tired). The patient was treated with IBUPROFEN (ADVIL ARTHRITIS PAIN) ongoing since an unknown date for Pain, at a dose of 1 dosage form; PREDNISONE ongoing since an unknown date for Pain, at a dose of 1 dosage form and HYDROXYCHLOROQUINE ongoing since an unknown date for Pain, at a dose of 1 dosage form. On 16-Jan-2021, FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient treated pain with heat & ice packs, then was put on steroid.  Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-102973 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Non-significant follow up & added reporters address only
Report red itchy spots at the injection site 2 post vaccination. Treatment: Outcome : does not interfere with ADLs.
On 7/2/15, pt presented with erythema, swelling and soreness at site of varicella vaccination received on 6/30/15. First s/s noted by pt 24 hrs after vaccination. Resolved without treatment and no complications.
I had a stroke hospitalized overnight.  Ow going to see neurologists and cardiologists
Headache, Myalgia, CoughWheeze, Fatigue Narrative:  Took OTC ibuprofen.
Shortness of breath; Headache; temperatures right under 100; Dizziness; Weakness; Joint pain; This is a spontaneous report received from a contactable consumer (patient's wife) and a consumer (patient). This consumer reported similar events for two patients. This is the second of two reports. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN6198 and Expiration date: not reported) via an unspecified route of administration on 22Feb2021 (at the age of 67 years old) as dose 2, single for COVID-19 immunisation. The patient was diabetic (ongoing; diagnosed about 6-7 years ago). Concomitant medication was not reported. The patient previously received the 1st dose of BNT162B2 (Lot number: EL9262) on an unspecified date for COVID-19 immunisation and did not feel anything. On 23Feb2021, the patient experienced shortness of breath and a headache (for 3 or 4 days). On unspecified dates in 2021, the patient also experienced "temperatures right under 100", dizziness, weakness, and joint pain. The patient was almost brought to the hospital due to shortness of breath but decided it wasn't bad enough and the patient was just uncomfortable, and that went away. The patient has missed work all week. The outcome of the events shortness of breath was recovered on an unspecified date in Feb2021; headache, dizziness, and weakness were recovering; joint pain was not recovered; while "temperatures right under 100" was unknown.  No follow-up attempts are needed. No further information is expected. Sender's Comments: Linked Report(s) : PFIZER INC-2021223797 Same reporter/product, similar events, different patient.
pt recv vax 13JUL94; PM devel fever; 15JUL high fever of 103 & bulging fontanelle; hospitalized 16JUL; CT scan & cultures neg; spinal tap showed blood cells but no abn WBC; rx Rocephin; fever cont w/lethargy; 19JUL sx resolving;
1) Steady, severe aching pain in center to upper right shoulder and pain into right upper arm. 2) Unaccounted for weight loss and bloody stools. Steady and unknown weight loss form 210lbs to 158 lbs over 8 months.   3) Chronic neurologic and gastro problems which I experience to this day. 4) Walnut sized hole (2.8 x 1.9 x 3.6 cm)in right hip bone w/lesions at injection site per MRI dtd 4/28/03. 5) Blood CRP recorded at 3.53mg/l on 5/29/03 (Normal range 0.00 to 0.55)
Information has been received from a nurse practitioner concerning a 4 year old male who was vaccinated with a dose of varicella virus vaccine live. The NP reported that the patient subsequently developed shingles along his waist/midline area. Unspecified medical attention was sought. At the time of this report, the outcome was unknown.
pain in the liver; not feeling well: he has nausea, headache, pain in the kidney and liver, vomiting.; nausea; headache; vomiting; pain in the kidney; not been able to go to work in 4 days; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on 14Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported that he got the first dose of the Pfizer covid vaccine on Wednesday 14Apr2021 and since that week he had been not feeling well he had nausea, headache, pain in the kidney and liver, vomiting. He said that he cannot tolerate food and water and throws them up. He felt so bad that he had not been able to go to work in 4 days and he had gone to 2 different hospitals but not one doctor was able to prescribe anything since they don't know what he had. He just wanted to report his side effects and get some help to get his health back. The outcome of all the events was unknown.  No follow-up attempts are needed. No further information is expected.
1st night started w/fever - flu symptoms - "3 days" Then swelling in the arm where the shot was given, shoulder coupled in size. The swelling took 1.5 wks to subside.
This case was reported by a healthcare professional (nurse) via sales representative and described the occurrence of injection site reaction in an unknown number of subjects of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). In 2013 the subjects received a dose of FLULAVAL (.5 ml, unknown site, unknown arm). In 2013, immediately after vaccination with FLULAVAL, the subjects experienced injection site reaction. The nurse stated that an unknown number of subjects ("about a handful, maybe 5") told the nurse that they "felt like the vaccine was draining down their arm. The nurse also felt that the FLULAVAL vaccine was very thick like corn syrup." No product complaint was associated with this case. The nurse did not know if the subjects sought medical attention. At the time of reporting the outcome of the event was unspecified.
This case was reported by a pharmacist via sales rep and described the occurrence of shingles in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. The reporter considered the shingles to be unrelated to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient had an episode of shingles before the second dose was given, reporter did not think it was related to vaccine.
Received H1N1 on 4-21-2010. By noon the next day had a bad headache(top of head and temporal area). Has had a headache every day since. Saw the MD at Clinic on May 11th. No tests or prescription med ordered. Patient states it was recommended she take Ibuprofen as needed. She has been taking this. It helps but the headache reoccurs. States the headache worse when sneezing. Patient states the MD advised a recheck in 3 months. She has not as yet made this appointment. Patient has high blood pressure- on medications. States the MD said her BP was ok on the date of her visit. No complaints other than the headache.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient received BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Lot number: EN6202), in left arm, on 22Mar2021 as dose 2, single (Lot number: EN6206), in left arm, on 04Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 08Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 53 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hashimoto's Thyroiditis" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "Insulin resistance" (unspecified if ongoing); "Penicillin" (unspecified if ongoing). Concomitant medication(s) included: XYZAL, start date: 01Apr2022; PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE], start date: 01Jun2022; FLONASE [FLUTICASONE PROPIONATE], start date: 01Apr2022. Past drug history included: Aspiring, reaction(s): "Known allergies: Aspirin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Course: COVID 19 Treatment was Paxlovid (lot number: GA7394) on 27Jun2022 and stop date on 01Jul2022. All other medication used in 2 weeks. The adverse event Rebound infection started on 06Jul2022 at 09:30 am results. No treatment for AE. The event was recovering.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a 62-year-old female patient who received SHINGRIX (batch number D3L5G, expiry date 29th November 2020) for prophylaxis. Concurrent medical conditions included chronic lymphocytic leukemia (treated, the patient was not in immunocompromised position). On 15th June 2018, the patient received SHINGRIX (intramuscular). On 16th June 2018, 1 days after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The health care professional reported that patient experienced flu like symptoms beginning the day after receipt of the vaccine and the symptoms lasted for a day or 2 then resolved. The patient received SHINGRIX on right deltoid. This is 1 of the 4 cases reported by same reporter.
Took a nap after shot then woke up with chest pains that went away then Can back again later that night which caused me to go to the emergency room. I was told to take pain medications and I still have pains that are not as painful as the first week.
Emergency hospital visit on 6/22/2021 for high blood sugar and symptomatic. Glucose at bedside point of care was 548 on 6/22/2021 at 2153 and 395 on 6/22/2021 at 2304. During emergency encounter, based on EHR record, sodium chloride 0.9% infusion at 200 mL/hr, Intravenous, CONTINUOUS, Starting on Tue 6/22/21 at 2053 and insulin regular (human) (HumuLIN R) 100 units in sodium chloride 0.9% 100 mL infusion administered at 2153 CDT at 5 Units/hr or 5mL/hr. Impression provided by attending radiology provider, "Mild diffuse interstitial thickening throughout both lungs. Faint interstitial infiltrate at the lung bases, right greater than left. Minimal blunting of the right costophrenic angle. Normal cardiac and mediastinal contours. No pneumothorax. Percutaneous gastrostomy tube in place."
I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 3/14/2022 ST ELEVATION MI INVOLV OTH CORONARY ART INF WALL
1st dose: 037K20A Dec 30, 2020 - 5 weeks along, date of miscarriage 1/12 arm pain swelling itching for a few days, fatigue aches, fevers, nausea, no vomitting, joint pain, my entire body hurt inside and out, chills, I also didn't sleep well, I was alternating tylenol and motrin, I drank lots of fluids I called my employee health for my symptoms I didn't go to the Dr. symptoms only lasted about 48 hours
10/3/2022 I had a little trouble breathing and tired. I am seeing my cardiologist tomorrow. I have not recovered.
Patient had grand mal seizure while sitting on a toilet. He fell from toilet and hit his head on floor.
Immediately after DTap was administered client developed redness and swelling at injection site size of 50 cents.  Ice pack applied and Benadryl Liquid 3/4 tsp given. Client observed for 20 minutes and signs and symptoms improved before leaving clinic.  No SOB or difficulty breathing.
Developed iritis form of uveitis shortly after getting vaccine. Felt feverish and very fatigued and sore the day after the vaccine (3/19/21), which was unexpected as I am generally healthy and do not recall having an adverse reaction to a vaccine before. Noticed prominent symptoms of iritis by around 2/22/21, but they may have been occurring earlier as I did not know what was happening to me. Symptoms started off as occasional aching of my right eye, but it eventually got inflamed and extra sensitive to light, and I experienced worse redness and aching/pain and photosensitivity by 2/26/21 when I scheduled an appointment with an optometrist. Pain/sensitivity was intermittent from 2/26/21 to  3/1/21, but redness remained. On 3/1/21, my optometrist tentatively diagnosed me with mild iritis and referred me to an opthalmologist. On 3/1/21, an opthalmologist diagnosed me with iritis/anterior uveitis, and I began a treatment of prednisolone acetate 1% drops. thought my development of iritis may have been related to me getting my first dose of the Covid-19 Moderna vaccine shortly before getting symptoms. Hoping to recover within  a few weeks. Have a follow-up appointment scheduled for 3/10/21.
Woke up from being asleep with moderate pain in injection site, mild headache that has rapidly intensified into a moderate headache, body aches and chills began around 130 am and have continued. Took advil around 1 am for headache and has not helped.  Low grade temp was recorded at 150 am of 99.9.
Bilateral feet numbness and tingling, neck numbness and discomfort, headaches , difficulty swallowing, drooling , choking. Dysphagia
little bulging bump with redness; red allergic bump is a 1-2 cm spot that appeared after 2 days below the injection site;  there is a little bulging bump with redness; feels that her second dose of the covid 19 vaccine was administered improperly; This is a spontaneous report from a contactable consumer (patient's friend). A 34-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number and Expiration date: unknown), dose 2 via an unknown route of administration, in left arm on Jan2021 (at the age of 34 years age of vaccination) as 2nd dose, single dose for covid-19 immunisation and patient received the first dose of bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number and Expiration date: unknown) dose 1 via an unknown route of administration on an unspecified date single dose for COVID-19 immunisation. The patient medical history was unknown. The patient's concomitant medications were not reported. On an unknown date in Jan 2021, the patient's friend reported that, his friend feels that her second dose of the covid 19 vaccine was administered improperly. The injection was administered on the patient's left arm and that the patient felt the medication was not administered properly and she did not fully receive the second dose. She wanted to know if she can repeat the second dose. The reporter experienced the red allergic bump was a 1-2 cm spot that appeared after 2 days below the injection site, there was a little bulging bump with redness on an unknown date in Jan 2021. It was reported that the, patient was concerned as she wanted to be fully vaccinated and if could get another dose. The outcome of events was unknown.   Follow-up (01Feb2021): This is a follow-up spontaneous report from a contactable consumer. Patient information and new event information was added  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Information has been received from an employee in a physician's office concerning an 8 year old female who on 01-OCT-1999 was vaccinated SC in the left arm with a first dose of Varivax (lot # 631303/0726J). There was no illness at the time of vaccination. The mother called the office reporting symptoms of fever, headache, muscle aches, and "spots" on the body that started on 17-JUN-2006. The patient had a fever of 102 to 103 for two days. The rash was described as scattered fluid-filled lesions, some of which were crusted. The patient complained of itching. The patient was exposed to varicella at the end of May 2006. The patient was examined in the office and was found to have 75 to 100 lesions on the scalp, face, back, chest, and legs. The mother noted that the rash started on 15-JUN-2006. No diagnostic laboratory tests were performed. A supportive treatment plan was noted. Additional information is not expected.
Moderna COVID-19 Vaccine EUA Soreness at injection site, nausea and vomiting - one hour,   severe headache, 4 hours,  fatigue  8 hours
Sore throat; Feverish; Moderate lethargy; Severe headaches; Moderately out of breath with workouts.; Localized mild aching of the site; localized mild aching of the site and discoloration; Mild overall tiredness/moderate overall tiredness; Slightly out of breath with regular tasks/moderately out of breath with daily activity; This is a spontaneous report from a contactable healthcare professional. A 26-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 22Apr2021 at 17:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, attention deficit hyperactive disorder (adhd), anxiety, depression and unknown autoimmune disorder. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), desogestrel/ethinylestradiol (APRI), sertraline hydrochloride (ZOLOFT), cyanocobalamin(B12) and colecalciferol (VITAMIN D3); all for unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 12:00, day two the patient experienced localized mild aching of the site and discoloration, mild overall tiredness and slightly out of breath with regular tasks, day three (24Apr2021) moderate overall tiredness and moderately out of breath with workouts, day four (25Apr2021) severe headaches, moderately out of breath with daily activity, day five (26Apr2021) sore throat, feverish and moderate lethargy. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events localized mild aching of the site and discoloration, mild overall tiredness, slightly out of breath with regular tasks, moderately out of breath with workouts, severe headaches, sore throat, feverish and moderate lethargy were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Immunization 2 days ago now warm, slight pruritis, swelling, pain moderate left arm.
Mother called on 10-8-08 with complaints of raised area at injection site, approx 2 inches in diameter with sm. blister in center. Area hot, red, swollen. Advised cool compress, Tylenol.
The Tdap injection was giving very high on my arm - almost in my shoulder. Intense pain began by the following day, making it nearly impossible for the next two weeks to use my arm or fall asleep, even with double doses of ADVIL. After that, the pain level began to subside, although I could not use my arm for many things without a recurrence of intense pain. Not able to lift arm above shoulder level, tuck in a shirt, remove pullover clothing, use arm during showering or driving or pick things up. I contacted the senior pharmacist by letter, to ask that they review the injection procedure with the employee who had given me the vaccine, but stressed that I did not wish to blame anyone for the unintentional injury. The pharmacist called me and he explained the reasoning for giving the injection in the upper arm/shoulder location; and did say that is  a small possibility that pain can result. He seemed very concerned and planned to discuss procedure with employees who give injections. I also contacted my family physician to suggest that the clinic and hospital lab personnel were reminded or made aware of the possible side effects of an injection in or near the shoulder. The clinic sent me the VAERS form. It is not six weeks since the injury. I still use pain relievers, especially at night, but not around the clock anymore. Sleeping in still very uncomfortable and the use of my left arm is limited in the same ways (driving, dressing, showering, etc). On researching what this condition might be called, I came across a site with CDC information about vaccination injuries that clearly described my symptoms. Then I researched what parts of the shoulder are involved. And found that the pain, lack of use etc. matched those of a rotator cuff injury. So, I am trying to follow recommendations for that condition by resting the shoulder and not trying to 'exercise the pain away' but using moist heat and gentle movement only. Sounds like healing can take weeks or months. I have not been to a doctor or therapist. If my home therapy does not help within another week or so, I will probably need to get professional help for it. I feel that perhaps that high arm/shoulder procedure for injecting vaccines should probably be discontinued because of the possible injuries involved.
On 8/15/21 loss of taste,  By 8/19/21. Headaches, sore throat.  Tested Positive for COVID